Model
Edge
Acrivon Therapeutics Inc.
0002013475
Filing Type
4
Filing Date
3/5/2024
Updated
3/6/24, 9:32 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership